alexa

GET THE APP

12-O-Tetradecanoylphorbol-13-Acetate for Refractory Secondary Acute Myeloid Leukemia

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

12-O-Tetradecanoylphorbol-13-Acetate for Refractory Secondary Acute Myeloid Leukemia

In December 2011, a 42-year-old woman was referred to our department. The patient was previously diagnosed with breast cancer in June 2009. She received 6 courses of chemotherapy after having breast tumor resection, and achieved complete remission (CR) after chemotherapy.

Lin Q, Fang B, Li Y, Du J, Song Y (2015) 12-O-Tetradecanoylphorbol-13-Acetate for Refractory Secondary Acute Myeloid Leukemia. J Leuk (Los Angel) (Los Angel) 3:168.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top